Latest News for: stromal cell

Edit

Graft Versus Host Disease Market is Projected for Substantial Expansion from USD 1.3 Billion in ...

GetNews 13 Mar 2025
... targeted and cell-based therapies ... Upcoming milestones may include potential label expansions of cellular therapies like mesenchymal stromal cells, which could redefine first-line treatment strategies.
Edit

Graft Versus Host Disease Market Expected to rise, 2034 | Biocon, medac GmbH, MaaT Pharma, ...

GetNews 12 Mar 2025
Ryoncil is the first mesenchymal stromal cell therapy authorized for pediatric patients aged two months and older whose GVHD symptoms have not responded to standard steroid therapy ... cell engraftment.
Edit

Doctor reveals 4 hidden signs of ovarian cancer - including a surprising one at mealtime

The Times of India 06 Mar 2025
The less common ovarian cancers include germ cell tumours and stromal tumours.Ovarian cancer mostly affects older women over 50, but can also impact younger women.Ovarian cancer risk increases with age, especially after menopause.
Edit

Is missed period a sign of ovarian cancer? Doctor explains

Hindustan Times 05 Mar 2025
Ovarian cancer is often referred to as the silent killer, said Dr ... Germ cell cancer ... Sex cord stromal cancer ... However, sex cord stromal tumors, which secrete hormones, can lead to hormonal imbalances and menstrual disturbances, including missed periods.
Edit

The Future of Stem Cell Investing: Spotlight on Smaller Innovators

GetNews 04 Mar 2025
The global stem cell therapy market is entering an era of unprecedented growth and innovation ... One of its major advancements is RYONCIL, a mesenchymal stromal cell (MSC) therapy that received FDA approval in December 2024.
Edit

Mestag Therapeutics Appoints Dr. Matthew Sleeman as Chief Scientific Officer

Pharmiweb 04 Mar 2025
... program, an agonist antibody targeting a stromal inhibitory receptor to dampen down the activation of specific immune cell subsets in inflammatory disease; and earlier programs in discovery stage.
Edit

Highlighting The Role Of Fibro-Adipogenic Progenitors In Muscle Regeneration And Degeneration

MENA FN 02 Mar 2025
(MENAFN - EIN Presswire) Multi-lineage differentiation of Pdgfra+ stromal cells in vitro and in vivo. Pdgfra+ stromal cells have multipotent capacity in different conditions. Representative signals ... .
Edit

The debate on MSCs is over; it's time to promote MSC therapy in practice

Walker & Catoosa County News 27 Feb 2025
26, 2025 /PRNewswire/ -- The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application.
  • 1
×